New RNA drug shows promise for Hard-to-Treat cholesterol disorders
NCT ID NCT03747224
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This early-stage study tested a new medicine called ARO-ANG3 in 93 healthy adults and people with high cholesterol or high triglycerides. The main goal was to see if the drug is safe and how the body processes it. This is a first step toward a possible new treatment for lipid disorders, but more research is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Nedlands, 6009, Australia
-
Research Site 2
Camperdown, New South Wales, 2050, Australia
-
Research Site 3
Adelaide, South Australia, 5000, Australia
-
Research Site 4
Grafton, Auckland, 1010, New Zealand
-
Research Site 5
Papatoetoe, Aukland, 2025, New Zealand
-
Research Site 6
Christchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.